Treat depression with just medication and spare patients the profound effects of the disease on their mental lives, their cognitive abilities, and their social lives? A dream that we hardly imagine will come true, because this psychiatric pathology is so complex and multifactorial. But there is an urgent need to improve care. 30% of people with major depression do not respond to existing treatments. However, the disease is anything but rare. It affects more than 2 million people in France and is on the verge of becoming the leading cause of disability by 2030, according to the World Health Organization.
What if the answer is hidden right in the heart of our neurons? This is the path chosen by a team of French and Canadian researchers. They developed a new compound that this Tuesday awarded CNRS Research Director Jocelyn Caboch the 2023 Marcel Dassault* Prize for Innovation in Psychiatry…
Source: Le Figaro
I am John Sinkler, a professional writer and journalist for Buna Times. I specialize in writing about entertainment-related topics and have been doing so for several years now. My work has been featured on multiple platforms and I’m proud to say that it’s gained recognition from many people in the industry. Aside from working at Buna Times, I also write freelance articles for other publications.